SICURANZA ANNA

Anna
Sicuranza
Ricercatore Legge 240/10 - tempo determinato

Contacts

329/4821482

Teaching activities

Completion accademic year: 2020/2021

Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2018/2019

Completion accademic year: 2019/2020

Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2017/2018

Completion accademic year: 2018/2019

Research

Latest publications:

  • Caocci, G., Mulas, O., Annunziata, M., Luciano, L., Abruzzese, E., Bonifacio, M., et al. (2020). Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second- and third-generation tyrosine kinase inhibitors. INTERNATIONAL JOURNAL OF CARDIOLOGY, 301, 163-166. - view more
  • Cencini, E., Fabbri, A., Sicuranza, A., & Bocchia, M. (2019). Prognostic significance of lymphocyte/monocyte count and neutrophil/lymphocyte count in peripheral T cell lymphoma. LEUKEMIA RESEARCH, 77, 5-7. - view more
  • Raspadori, D., Pacelli, P., Sicuranza, A., Abruzzese, E., Iurlo, A., Cattaneo, D., et al. (2019). Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia. CYTOMETRY. PART B, CLINICAL CYTOMETRY, 96(4), 294-299. - view more
  • Bocchia, M., Candoni, A., Borlenghi, E., Defina, M., Filì, C., Cattaneo, C., et al. (2019). Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy. HEMATOLOGICAL ONCOLOGY, 37(4), 447-455. - view more
  • Cencini, E., Sicuranza, A., Fabbri, A., Ferrigno, I., Rigacci, L., Cox, M.C., et al. (2019). Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab. BRITISH JOURNAL OF HAEMATOLOGY, 184(2), 223-231. - view more